###begin article-title 0
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Inducible Cre recombinase activity in mouse mature astrocytes and adult neural precursor cells
###end article-title 0
###begin p 1
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
Two transgenic mouse lines expressing an inducible form of the Cre recombinase (CreERTM) under the control of the human GFAP promoter have been generated and characterized. In adult mice, expression of the fusion protein is largely confined to astrocytes in all regions of the central nervous system. Minimal spontaneous Cre activity was detected and recombination was efficiently induced by intraperitoneal administration of tamoxifen in adult mice. The pattern of recombination closely mirrored that of transgene expression. The percentage of astrocytes undergoing recombination varied from region to region ranging from 35% to 70% while a much smaller portion (<1%) of oligodendrocytes and neural precursor cells showed evidence of Cre activity. These mouse lines will provide important tools to dissect gene function in glial cells and in gliomagenesis.
###end p 1
###begin title 2
Keywords
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2007</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">2007</xref>
Astrocytes are the most abundant glial cell type in the mammalian brain and play important roles in all aspects of the developing and mature organ (He and Sun 2007). This includes, but is not restricted to a housekeeping function in support of neurons, the establishment and maintenance of the blood-brain barrier and the regulation of synaptogenesis and synaptic plasticity. It is perhaps not surprising then, that astrocytes are proposed to be at the root of numerous pathological processes such as glial scarring following brain injuries, Alexander disease and the most common primary brain tumor, glioma (He and Sun 2007). The availability of the appropriate molecular tools to manipulate gene expression in vivo is therefore critical to further our understanding of astrocyte contributions to normal and disease states.
###end p 4
###begin p 5
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">2007</xref>
###xml 306 310 306 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">1996</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">1995</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2003</xref>
###xml 998 1002 998 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1186 1194 1186 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP-cre</italic>
###xml 1239 1243 1239 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">2002</xref>
###xml 1265 1269 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">2006</xref>
###xml 1285 1289 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">2004</xref>
###xml 1303 1307 1303 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">2001</xref>
###xml 1323 1327 1323 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">2000</xref>
###xml 1344 1348 1344 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">2005</xref>
###xml 1362 1366 1362 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">2001</xref>
###xml 1500 1504 1500 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 33 49 <span type="species:ncbi:10678">bacteriophage P1</span>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
###xml 323 338 <span type="species:ncbi:10090">transgenic mice</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 1195 1199 <span type="species:ncbi:10090">mice</span>
###xml 1509 1513 <span type="species:ncbi:10090">mice</span>
A large number of brain-specific bacteriophage P1 Cre recombinase-expressing mouse strains have been developed, including those using the glial fibrillary acidic protein (GFAP) promoter to drive astrocyte-specific expression of cre (Gaveriaux-Ruff and Kieffer 2007). The expression pattern directed by the GFAP promoter in transgenic mice has been extensively studied and mapped (Brenner and Messing 1996; Johnson et al. 1995). In adult mice its activity is restricted predominantly to astrocytes while embryonic expression targets neural precursor cells of the ventricular zone and spinal cord. In addition, a subset of Gfap-expressing glial cells located in the subventricular zone of the adult brain have been shown to function as adult neural stem cells capable of giving rise to the major cell types in the brain: mature astrocytes, oligodendrocytes and neurons (Doetsch 2003). Because Cre-mediated recombination is irreversible, embryonic expression in neural precursor cells directed by the GFAP promoter and/or aberrant expression resulting from transgene insertion effects have resulted in substantial Cre-mediated recombination in mature neurons as well as glial cells in all GFAP-cre mice characterized to date (Bajenaru et al. 2002; Casper and McCarthy 2006; Fraser et al. 2004; Kwon et al. 2001; Marino et al. 2000; McCarty et al. 2005; Zhuo et al. 2001). Therefore, the ability to restrict Cre activity during embryogenesis could greatly mitigate neuronal Cre-mediated recombination in GFAP-Cre mice and allow for the study of gene function in mature astrocytes without disruption of function in neurons.
###end p 5
###begin p 6
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">1996</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2002</xref>
###xml 303 305 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 467 469 467 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 586 588 586 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">2002</xref>
###xml 860 862 860 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 826 831 <span type="species:ncbi:10090">mouse</span>
###xml 903 908 <span type="species:ncbi:9606">human</span>
Cre activity can be regulated in a temporal fashion by engineering a fusion protein with the ligand binding domain of a steroid hormone receptor, such as the estrogen receptor (Feil et al. 1996; Hayashi and McMahon 2002). Furthermore, a specific point mutation within the ligand-binding domain termed ERTM abolishes the binding to endogenous steroid hormones while retaining its interaction with synthetic estrogen analogs such as tamoxifen. The fusion protein, CreERTM, is inactive while sequestered in the cytoplasm by heat shock protein complexes. Binding of tamoxifen releases CreERTM from this complex allowing ligand-dependent translocation to the nucleus where the fusion protein is active and directs recombination between loxP sites (Hayashi and McMahon 2002). In this report, we describe the characterization of two mouse strains expressing the CreERTM fusion protein under the control of the human GFAP promoter.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Transgenic and reporter mice
###end title 8
###begin p 9
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">1994</xref>
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 701 704 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 996 997 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 998 1000 992 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 1072 1076 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2000</xref>
###xml 1146 1149 1140 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFP</italic>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 448 452 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 863 867 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 883 888 <span type="species:ncbi:10090">mouse</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1010 1015 <span type="species:ncbi:10090">mouse</span>
###xml 1097 1101 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
###xml 1334 1342 <span type="species:ncbi:9606">Children</span>
Standard subcloning techniques were used to construct the transgene placing the 2.2 Kb human GFAP promoter (a gift from D. Gutmann) (Brenner et al. 1994) upstream of the cDNA encoding the CreERTM fusion protein (provided by A. McMahon). This was followed by an internal ribosomal entry sequence (IRES) and the cDNA encoding bacterial beta-galactosidase (beta-gal) to facilitate detection of transgene expression. The construct was terminated by an SV40 intronic sequence and polyadenylation signal. Following pronuclear injection into fertilized FVB/NJ oocytes and implantation into foster mothers, the transgenic founder was identified by polymerase chain reaction (PCR) with primers recognizing the Cre sequence (5' AGCGATCGCTGCCAGGAT 3' and 5' ACCAGCGTTTTCGTTCTGCC 3'). Integration of the transgene was confirmed by Southern blot using a probe recognizing the SV40 sequences. The mouse line was propagated by crossing with FVB/NJ wild-type mice. Cre activity was assessed by crossing into the Z/EG reporter mouse line (Jackson Laboratory, Bar Harbor, ME) (Novak et al. 2000). Reporter positive mice were identified by PCR using primers to the GFP gene (5' CCGGGGTGGTGCCCATCCTGGT 3' and 5' GCTCCTGGACGTAGCCTTCGGGC 3'). All experiments involving mice were carried out in compliance with the Animal Care and Use Committee at St. Jude Children's Research Hospital.
###end p 9
###begin title 10
Induction of Cre activity
###end title 10
###begin p 11
###xml 50 54 <span type="species:ncbi:381124">corn</span>
###xml 371 375 <span type="species:ncbi:381124">corn</span>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
Tamoxifen (Sigma, St. Louis, MO) was dissolved in corn oil (Sigma) at a concentration of 20 mg/ml at 37degreesC, and then filter sterilized and stored for up to 7 days at 4degreesC in the dark. A 27 g needle tuberculin syringe (Becton Dickinson, Franklin Lakes, NJ) was used for intraperitoneal injections at the indicated doses. An equivalent volume of sterile filtered corn oil alone was used for vehicle injections. Multiple injections in the same mouse were separated by 24 h.
###end p 11
###begin title 12
Histochemistry
###end title 12
###begin p 13
Animals were perfused with 1x phosphate-buffered saline (PBS) followed by 2% paraformaldehyde (PFA) in PBS. Following dissection, tissues were post-fixed overnight in 2% PFA in PBS at 4degreesC, and then equilibrated to 25% sucrose in PBS for a further 24 h at 4degreesC. Tissues were subsequently embedded and cryosectioned at a thickness of 12 mum. Tissue slides were washed three times in PBS prior to staining.
###end p 13
###begin p 14
###xml 78 79 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 98 99 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 155 156 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 174 175 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 328 329 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 348 349 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 397 398 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 404 405 395 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 413 414 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 420 421 411 412 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
For detection of beta-gal activity, slides were washed in Rinse A (100 mM NaPO4, pH 7.3; 2 mM MgCl2; 5 mM EGTA) for 30 min followed by Rinse B (100 mM NaPO4 pH 7.3; 2 mM MgCl2; 0.01% sodium deoxycholate; 0.02% NP-40) for 5 min. Slides were then stained at 37degreesC for 3-4 days in Developing Buffer (1 mg/ml X-gal; 100 mM NaPO4; pH 7.3; 2 mM MgCl2; 0.01% sodium deoxycholate; 0.02% NP-40; 5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6). After washing extensively in PBS, slides were counterstained with Nuclear Fast Red (Vector Labs, Burlingame, CA).
###end p 14
###begin title 15
Immunohistochemistry and immunofluorescence
###end title 15
###begin p 16
###xml 639 640 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 525 536 <span type="species:ncbi:3704">horseradish</span>
Cryosections were prepared as above. Primary antibodies used for immunodetection were against GFP (1:5000 for immunohistochemistry, 1:500 for immunofluorescence; Molecular Probes, Eugene, OR), S100beta (1:200; Sigma), NeuN (1:500; Chemicon, Temecula, CA), CC-1 (1:50; Calbiochem, San Diego, CA), Gfap (1:200; Sigma) and S100 (1:500; Dako, Carpinteria, CA). Microwave antigen retrieval was performed for all antibodies except anti-GFP. For immunohistochemistry, biotinylated secondary antibodies were used in conjunction with horseradish peroxidase-conjugated streptavidin (Elite ABC, Vector Laboratories) treated with NovoRed or VIP (Fig. 5) substrate (Vector Laboratories) and counterstained with hematoxylin or methyl green (Vector Laboratories), respectively. For immunofluorescence, Alexa Fluor 488 (Molecular Probes) and cyanine 3 (Jackson Immunoresearch, West Grove, PA) conjugated secondary antibodies were employed along with Vectashield mounting media containing 4',6-diamino-2-phenylindole (Vector Laboratories).
###end p 16
###begin title 17
Quantitation
###end title 17
###begin p 18
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 107 109 107 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 978 983 <span type="species:ncbi:10090">mouse</span>
The percentage of astrocytes undergoing Cre-mediated recombination was determined in five GFAP-CreERTMA; Z/EG mice injected with 9 mg/40 g body weight tamoxifen daily for 5 days. Serial cryosections were stained with S100 and GFP and positively stained cells (identified by visibly stained nucleus) from equivalent surface areas in various regions of the brain were counted with the aid of the Bioquant system (Bioquant Image Analysis Corp., Nashville, TN). The average number of cells counted in each mouse for the cerebellum, cortex, hippocampus and thalamus/hypothalamus was 1260, 1430, 490, and 2500, respectively. For oligodendrocytes, CC-1 positive cells in the corpus callosum of cryosections from two brains were counted (3220 cells each) and compared to the number of double positive CC-1 and GFP staining cells in an adjacent section. The total number of subventricular zone nuclei in sections from four different animals was determined (an average of 2260 nuclei per mouse) and compared to the number of GFP positive cells in the same sections.
###end p 18
###begin title 19
Results
###end title 19
###begin p 20
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 127 131 127 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">1994</xref>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.&#160;coli</italic>
###xml 494 498 488 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 499 504 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 504 506 498 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 560 563 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 631 632 625 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 766 769 760 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 801 804 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cre</italic>
###xml 958 962 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 963 968 957 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 968 970 962 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 970 971 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 978 979 972 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 997 1001 991 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1002 1007 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1007 1009 1001 1003 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1009 1010 1003 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1017 1018 1011 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1194 1198 1188 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1199 1204 1193 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1204 1206 1198 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1299 1305 1293 1299 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1344 1345 1338 1339 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1397 1401 1391 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1501 1503 1495 1497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1564 1571 1558 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.&#160;coli</italic>
###xml 1604 1605 1592 1593 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1714 1717 1702 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1796 1797 1784 1785 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2031 2035 2019 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 2036 2041 2024 2029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 2041 2043 2029 2031 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 2043 2044 2031 2032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2065 2069 2053 2057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 2070 2075 2058 2063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 2075 2077 2063 2065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 2077 2078 2065 2066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 2167 2168 2155 2156 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1305 2169 1299 2157 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="21">Generation of transgenic mouse lines. (<bold>a</bold>) Diagram of transgenic construct. The 2.2&#160;Kb human <italic>GFAP</italic> promoter drives expression of cDNAs encoding the Cre-estrogen receptor ligand binding domain (CreER<sup>TM</sup>) fusion protein, an internal ribosome entry site (IRES) and <italic>E.&#160;coli</italic> &#946;-galactosidase (&#946;-gal). (<bold>b</bold>) Southern blot. Genomic DNAs from the transgenic founder mouse and a panel of F1 progeny were digested with <italic>Eco</italic>RI (location of restriction sites within the transgene are indicated in panel (<bold>a</bold>)) to detect fragments resulting from internal digest of the multicopy transgene as well as those containing the junction of the transgene with the insertion sites in genomic DNA. The fragments corresponding to the insertion site for <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> (arrowhead) and for <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> (arrow) are shown. The probe was directed against SV40 sequences as indicated in panel (<bold>a</bold>)</p>
###xml 1305 2169 1299 2157 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="21">Generation of transgenic mouse lines. (<bold>a</bold>) Diagram of transgenic construct. The 2.2&#160;Kb human <italic>GFAP</italic> promoter drives expression of cDNAs encoding the Cre-estrogen receptor ligand binding domain (CreER<sup>TM</sup>) fusion protein, an internal ribosome entry site (IRES) and <italic>E.&#160;coli</italic> &#946;-galactosidase (&#946;-gal). (<bold>b</bold>) Southern blot. Genomic DNAs from the transgenic founder mouse and a panel of F1 progeny were digested with <italic>Eco</italic>RI (location of restriction sites within the transgene are indicated in panel (<bold>a</bold>)) to detect fragments resulting from internal digest of the multicopy transgene as well as those containing the junction of the transgene with the insertion sites in genomic DNA. The fragments corresponding to the insertion site for <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> (arrowhead) and for <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> (arrow) are shown. The probe was directed against SV40 sequences as indicated in panel (<bold>a</bold>)</p></caption>
###xml 2169 2169 2157 2157 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig1_HTML" id="MO1"/>
###xml 1299 2169 1293 2157 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="21">Generation of transgenic mouse lines. (<bold>a</bold>) Diagram of transgenic construct. The 2.2&#160;Kb human <italic>GFAP</italic> promoter drives expression of cDNAs encoding the Cre-estrogen receptor ligand binding domain (CreER<sup>TM</sup>) fusion protein, an internal ribosome entry site (IRES) and <italic>E.&#160;coli</italic> &#946;-galactosidase (&#946;-gal). (<bold>b</bold>) Southern blot. Genomic DNAs from the transgenic founder mouse and a panel of F1 progeny were digested with <italic>Eco</italic>RI (location of restriction sites within the transgene are indicated in panel (<bold>a</bold>)) to detect fragments resulting from internal digest of the multicopy transgene as well as those containing the junction of the transgene with the insertion sites in genomic DNA. The fragments corresponding to the insertion site for <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> (arrowhead) and for <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> (arrow) are shown. The probe was directed against SV40 sequences as indicated in panel (<bold>a</bold>)</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig1_HTML" id="MO1"/></fig>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 250 257 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 324 328 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 887 891 <span type="species:ncbi:10090">mice</span>
###xml 1207 1212 <span type="species:ncbi:10090">mouse</span>
###xml 1330 1335 <span type="species:ncbi:10090">mouse</span>
###xml 1391 1396 <span type="species:ncbi:9606">human</span>
###xml 1564 1571 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 1663 1668 <span type="species:ncbi:10090">mouse</span>
###xml 2129 2133 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The cDNA encoding the CreERTM fusion protein was placed downstream of the 2.2 Kb human GFAP promoter (Fig. 1a) (Brenner et al. 1994). This was followed by an internal ribosomal entry site (IRES) and a LacZ cDNA encoding a nuclear-targeted version of E. coli beta-galactosidase (beta-gal). The construct was terminated by an SV40 large T intron and polyadenylation signal. After pronuclear injection of FVB/NJ eggs, one founder was obtained. Transgene integration in this line, hereafter termed GFAP-CreERTM, was verified by polymerase chain reaction (PCR) for Cre-specific sequences as well as by Southern blot hybridization (Fig. 1b). The latter result suggested the presence of two independent integration sites, a conclusion which was supported by a frequency of Cre-positive F1 progeny of 76% (63 Cre-positive out of 83 total pups). After several rounds of breeding to wild-type FVB mice, the two integration sites were separated into independent lines (GFAP-CreERTMA; Fig. 1b, lanes 6-8, and GFAP-CreERTMB; Fig. 1b, lanes 3-5). Furthermore, a single integration site in each line was verified by fluorescence in situ hybridization (FISH) for the transgene in MEF cells generated from each GFAP-CreERTM mouse line with chromosomal location of 9A5 for line A and 15E3 for line B (data not shown).Fig. 1Generation of transgenic mouse lines. (a) Diagram of transgenic construct. The 2.2 Kb human GFAP promoter drives expression of cDNAs encoding the Cre-estrogen receptor ligand binding domain (CreERTM) fusion protein, an internal ribosome entry site (IRES) and E. coli beta-galactosidase (beta-gal). (b) Southern blot. Genomic DNAs from the transgenic founder mouse and a panel of F1 progeny were digested with EcoRI (location of restriction sites within the transgene are indicated in panel (a)) to detect fragments resulting from internal digest of the multicopy transgene as well as those containing the junction of the transgene with the insertion sites in genomic DNA. The fragments corresponding to the insertion site for GFAP-CreERTMA (arrowhead) and for GFAP-CreERTMB (arrow) are shown. The probe was directed against SV40 sequences as indicated in panel (a)
###end p 20
###begin p 21
###xml 39 40 39 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 259 266 259 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.&#160;coli</italic>
###xml 299 300 293 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 409 412 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 491 492 485 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 726 730 720 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 731 736 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 736 738 730 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 738 739 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 760 764 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 765 770 759 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 770 772 764 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 772 773 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 862 863 856 857 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 86 91 <span type="species:ncbi:9606">human</span>
###xml 259 266 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
###xml 824 828 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Generation of transgenic mouse lines. (a) Diagram of transgenic construct. The 2.2 Kb human GFAP promoter drives expression of cDNAs encoding the Cre-estrogen receptor ligand binding domain (CreERTM) fusion protein, an internal ribosome entry site (IRES) and E. coli beta-galactosidase (beta-gal). (b) Southern blot. Genomic DNAs from the transgenic founder mouse and a panel of F1 progeny were digested with EcoRI (location of restriction sites within the transgene are indicated in panel (a)) to detect fragments resulting from internal digest of the multicopy transgene as well as those containing the junction of the transgene with the insertion sites in genomic DNA. The fragments corresponding to the insertion site for GFAP-CreERTMA (arrowhead) and for GFAP-CreERTMB (arrow) are shown. The probe was directed against SV40 sequences as indicated in panel (a)
###end p 21
###begin p 22
###xml 269 273 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">2006</xref>
###xml 289 293 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 294 299 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 299 301 293 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 517 518 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 742 743 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 933 934 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1005 1009 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2003</xref>
###xml 1148 1149 1127 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1243 1247 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2003</xref>
###xml 1311 1315 1287 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1316 1321 1292 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1321 1323 1297 1299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1693 1699 1666 1672 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1738 1742 1711 1715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1743 1748 1716 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1748 1750 1721 1723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1787 1788 1757 1758 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1789 1790 1759 1760 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1792 1796 1762 1766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1797 1802 1767 1772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1802 1804 1772 1774 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1804 1805 1774 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1814 1815 1784 1785 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1816 1817 1786 1787 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 1819 1823 1789 1793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1824 1829 1794 1799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1829 1831 1799 1801 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1831 1832 1801 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1841 1842 1811 1812 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1844 1845 1814 1815 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1889 1890 1859 1860 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1916 1917 1886 1887 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1921 1922 1891 1892 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1924 1925 1894 1895 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1927 1928 1897 1898 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1930 1931 1900 1901 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 1973 1974 1943 1944 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1976 1977 1946 1947 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1989 1990 1959 1960 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1992 1993 1962 1963 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 2017 2018 1987 1988 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2025 2026 1995 1996 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 2081 2082 2051 2052 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2110 2111 2080 2081 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 2126 2127 2096 2097 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2155 2156 2124 2125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 2160 2161 2129 2130 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 2163 2164 2132 2133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 2320 2321 2289 2290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 2350 2351 2318 2319 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 2355 2356 2323 2324 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 2358 2359 2326 2327 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 2498 2499 2466 2467 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 2527 2528 2494 2495 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 1699 2529 1672 2496 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23">Transgene expression analysis of adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup> brains by &#946;-gal histochemistry. (<bold>a</bold>&#8211;<bold>e</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> brain. (<bold>f</bold>&#8211;<bold>j</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> brain. (<bold>a</bold>, <bold>f</bold>) Sagittal sections of brain. Scale bar in (<bold>a</bold>) is 1&#160;mm and applies to (<bold>f</bold>). (<bold>b</bold>, <bold>c</bold>, <bold>g</bold>, <bold>h</bold>) Sagittal sections of cerebellum at low (<bold>b</bold>, <bold>g</bold>) and high (<bold>c</bold>, <bold>h</bold>) power. The arrows in (<bold>c</bold>) and (<bold>h</bold>) indicate the location of Bergman glia. Scale bar in (<bold>b</bold>) is 0.5&#160;mm and applies to (<bold>g</bold>) and that in (<bold>c</bold>) is 50&#160;&#956;m and applies to (<bold>h</bold>). (<bold>d</bold>, <bold>i</bold>) Sagittal sections through dentate gyrus. The arrows indicate the inner layer of the dentate gyrus, the location of neural progenitor cells. Scale bar in (<bold>d</bold>) is 100&#160;&#956;m and applies to (<bold>i</bold>). (<bold>e</bold>, <bold>j</bold>) Sagittal sections through subventricular zone. The arrows indicate a transgene-expressing cell in the subventricular zone. Scale bar in (<bold>e</bold>) is 10&#160;&#956;m and applies to (<bold>j</bold>)</p>
###xml 1699 2529 1672 2496 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23">Transgene expression analysis of adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup> brains by &#946;-gal histochemistry. (<bold>a</bold>&#8211;<bold>e</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> brain. (<bold>f</bold>&#8211;<bold>j</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> brain. (<bold>a</bold>, <bold>f</bold>) Sagittal sections of brain. Scale bar in (<bold>a</bold>) is 1&#160;mm and applies to (<bold>f</bold>). (<bold>b</bold>, <bold>c</bold>, <bold>g</bold>, <bold>h</bold>) Sagittal sections of cerebellum at low (<bold>b</bold>, <bold>g</bold>) and high (<bold>c</bold>, <bold>h</bold>) power. The arrows in (<bold>c</bold>) and (<bold>h</bold>) indicate the location of Bergman glia. Scale bar in (<bold>b</bold>) is 0.5&#160;mm and applies to (<bold>g</bold>) and that in (<bold>c</bold>) is 50&#160;&#956;m and applies to (<bold>h</bold>). (<bold>d</bold>, <bold>i</bold>) Sagittal sections through dentate gyrus. The arrows indicate the inner layer of the dentate gyrus, the location of neural progenitor cells. Scale bar in (<bold>d</bold>) is 100&#160;&#956;m and applies to (<bold>i</bold>). (<bold>e</bold>, <bold>j</bold>) Sagittal sections through subventricular zone. The arrows indicate a transgene-expressing cell in the subventricular zone. Scale bar in (<bold>e</bold>) is 10&#160;&#956;m and applies to (<bold>j</bold>)</p></caption>
###xml 2529 2529 2496 2496 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig2_HTML" id="MO2"/>
###xml 1693 2529 1666 2496 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="23">Transgene expression analysis of adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup> brains by &#946;-gal histochemistry. (<bold>a</bold>&#8211;<bold>e</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> brain. (<bold>f</bold>&#8211;<bold>j</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> brain. (<bold>a</bold>, <bold>f</bold>) Sagittal sections of brain. Scale bar in (<bold>a</bold>) is 1&#160;mm and applies to (<bold>f</bold>). (<bold>b</bold>, <bold>c</bold>, <bold>g</bold>, <bold>h</bold>) Sagittal sections of cerebellum at low (<bold>b</bold>, <bold>g</bold>) and high (<bold>c</bold>, <bold>h</bold>) power. The arrows in (<bold>c</bold>) and (<bold>h</bold>) indicate the location of Bergman glia. Scale bar in (<bold>b</bold>) is 0.5&#160;mm and applies to (<bold>g</bold>) and that in (<bold>c</bold>) is 50&#160;&#956;m and applies to (<bold>h</bold>). (<bold>d</bold>, <bold>i</bold>) Sagittal sections through dentate gyrus. The arrows indicate the inner layer of the dentate gyrus, the location of neural progenitor cells. Scale bar in (<bold>d</bold>) is 100&#160;&#956;m and applies to (<bold>i</bold>). (<bold>e</bold>, <bold>j</bold>) Sagittal sections through subventricular zone. The arrows indicate a transgene-expressing cell in the subventricular zone. Scale bar in (<bold>e</bold>) is 10&#160;&#956;m and applies to (<bold>j</bold>)</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig2_HTML" id="MO2"/></fig>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
###xml 1330 1334 <span type="species:ncbi:10090">mice</span>
Transgene expression was characterized by histochemistry for beta-gal activity in adult mouse brains. In wild-type mice, occasional histochemical staining was noted in cells of the pial membranes, representing endogenous beta-gal activity (data not shown) (Chow et al. 2006). In contrast, GFAP-CreERTM brains exhibited specific and reproducible patterns of beta-gal activity that were virtually identical between the two mouse lines. Cells expressing beta-gal were scattered throughout all regions of the brain (Fig. 2a, f), however, the specific pattern in certain areas was notable. In the cerebellum, many beta-gal positive cell bodies aligned along the Purkinje cell layer with cellular processes extending into the molecular layer (Fig. 2b, c arrows, g, h, arrows), a morphological feature consistent with Bergmann glia. In the dentate gyrus, beta-gal positive cells tended to cluster in the inner layer of this structure (Fig. 2d, i arrows) where neural precursor cells are known to reside (Doetsch 2003). Histochemical staining for beta-gal activity was also noted in cells of the subventricular zone surrounding the lateral ventricle (Fig. 2e, j arrows) where Gfap-expressing adult neural stem cells have also been identified (Doetsch 2003). No beta-gal activity was detected in a panel of tissues from GFAP-CreERTM adult mice including muscle, skin, lung, thymus, heart, liver, spleen, adrenal gland, pancreas, bladder, uterus, ovary and epididymus (data not shown). beta-gal activity was detected in the gastrointestinal tract, kidney and testis however this likely represents endogenous activity as similar staining was also noted in non-transgenic control animals (data not shown).Fig. 2Transgene expression analysis of adult GFAP-CreERTM brains by beta-gal histochemistry. (a-e) GFAP-CreERTMA brain. (f-j) GFAP-CreERTMB brain. (a, f) Sagittal sections of brain. Scale bar in (a) is 1 mm and applies to (f). (b, c, g, h) Sagittal sections of cerebellum at low (b, g) and high (c, h) power. The arrows in (c) and (h) indicate the location of Bergman glia. Scale bar in (b) is 0.5 mm and applies to (g) and that in (c) is 50 mum and applies to (h). (d, i) Sagittal sections through dentate gyrus. The arrows indicate the inner layer of the dentate gyrus, the location of neural progenitor cells. Scale bar in (d) is 100 mum and applies to (i). (e, j) Sagittal sections through subventricular zone. The arrows indicate a transgene-expressing cell in the subventricular zone. Scale bar in (e) is 10 mum and applies to (j)
###end p 22
###begin p 23
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 49 51 49 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 88 89 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 90 91 87 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 93 97 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 98 103 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 103 105 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 105 106 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 115 116 112 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 117 118 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 120 124 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 125 130 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 130 132 127 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 132 133 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 142 143 139 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 145 146 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 190 191 187 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 217 218 214 215 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 222 223 219 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 225 226 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 228 229 225 226 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 231 232 228 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 274 275 271 272 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 277 278 274 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 290 291 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 293 294 290 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 318 319 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 326 327 323 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 382 383 379 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 411 412 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 427 428 424 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 456 457 452 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 461 462 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 464 465 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 621 622 617 618 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 651 652 646 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 656 657 651 652 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 659 660 654 655 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 799 800 794 795 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 828 829 822 823 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
Transgene expression analysis of adult GFAP-CreERTM brains by beta-gal histochemistry. (a-e) GFAP-CreERTMA brain. (f-j) GFAP-CreERTMB brain. (a, f) Sagittal sections of brain. Scale bar in (a) is 1 mm and applies to (f). (b, c, g, h) Sagittal sections of cerebellum at low (b, g) and high (c, h) power. The arrows in (c) and (h) indicate the location of Bergman glia. Scale bar in (b) is 0.5 mm and applies to (g) and that in (c) is 50 mum and applies to (h). (d, i) Sagittal sections through dentate gyrus. The arrows indicate the inner layer of the dentate gyrus, the location of neural progenitor cells. Scale bar in (d) is 100 mum and applies to (i). (e, j) Sagittal sections through subventricular zone. The arrows indicate a transgene-expressing cell in the subventricular zone. Scale bar in (e) is 10 mum and applies to (j)
###end p 23
###begin p 24
###xml 59 61 59 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 134 136 134 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 162 164 162 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LoxP</italic>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">2000</xref>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 662 664 662 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 668 669 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 670 672 670 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 904 905 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 913 914 913 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1086 1087 1086 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1280 1284 1277 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1285 1290 1282 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1290 1292 1287 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1323 1324 1320 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1332 1333 1329 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1494 1495 1491 1492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1501 1502 1498 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1601 1602 1598 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1608 1609 1605 1606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1657 1658 1654 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1664 1665 1661 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1708 1709 1702 1703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1789 1790 1783 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1796 1797 1790 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1800 1806 1794 1800 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 1892 1893 1886 1887 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1894 1895 1888 1889 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1897 1898 1891 1892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1899 1901 1893 1895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 1979 1980 1973 1974 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1981 1982 1975 1976 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1984 1988 1978 1982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1989 1994 1983 1988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1994 1996 1988 1990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1996 1997 1990 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1999 2000 1993 1994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 2001 2003 1995 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 2228 2229 2222 2223 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 2230 2231 2224 2225 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 2233 2237 2227 2231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 2238 2243 2232 2237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 2243 2245 2237 2239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 2245 2246 2239 2240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2248 2249 2242 2243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 2250 2252 2244 2246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 2406 2407 2400 2401 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2409 2410 2403 2404 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 2412 2413 2406 2407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 2456 2457 2450 2451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2459 2460 2453 2454 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 2462 2463 2456 2457 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 2503 2504 2497 2498 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 2506 2507 2500 2501 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 2509 2510 2503 2504 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 1806 2558 1800 2552 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25">Cre-mediated recombination in adult brains by immunohistochemistry for GFP reporter. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>Z</italic>/<italic>EG</italic> single transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with vehicle daily for 5&#160;days. Inset represents images from an uninduced 14-month-old double transgenic mouse whereas all other mice presented are ~8&#160;weeks of age as indicated in the text. (<bold>g</bold>&#8211;<bold>i</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>, <bold>g</bold>), cerebral cortex and hippocampus (panels <bold>b</bold>, <bold>e</bold>, <bold>h</bold>) and thalamus and hypothalamus (panels <bold>c</bold>, <bold>f</bold>, <bold>i</bold>). Scale bar is 0.5&#160;mm and applies to all panels</p>
###xml 1806 2558 1800 2552 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25">Cre-mediated recombination in adult brains by immunohistochemistry for GFP reporter. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>Z</italic>/<italic>EG</italic> single transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with vehicle daily for 5&#160;days. Inset represents images from an uninduced 14-month-old double transgenic mouse whereas all other mice presented are ~8&#160;weeks of age as indicated in the text. (<bold>g</bold>&#8211;<bold>i</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>, <bold>g</bold>), cerebral cortex and hippocampus (panels <bold>b</bold>, <bold>e</bold>, <bold>h</bold>) and thalamus and hypothalamus (panels <bold>c</bold>, <bold>f</bold>, <bold>i</bold>). Scale bar is 0.5&#160;mm and applies to all panels</p></caption>
###xml 2558 2558 2552 2552 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig3_HTML" id="MO3"/>
###xml 1800 2558 1794 2552 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="25">Cre-mediated recombination in adult brains by immunohistochemistry for GFP reporter. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>Z</italic>/<italic>EG</italic> single transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with vehicle daily for 5&#160;days. Inset represents images from an uninduced 14-month-old double transgenic mouse whereas all other mice presented are ~8&#160;weeks of age as indicated in the text. (<bold>g</bold>&#8211;<bold>i</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>, <bold>g</bold>), cerebral cortex and hippocampus (panels <bold>b</bold>, <bold>e</bold>, <bold>h</bold>) and thalamus and hypothalamus (panels <bold>c</bold>, <bold>f</bold>, <bold>i</bold>). Scale bar is 0.5&#160;mm and applies to all panels</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig3_HTML" id="MO3"/></fig>
###xml 2558 2564 2552 2558 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 2600 2604 2594 2598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 2605 2610 2599 2604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 2610 2612 2604 2606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 2612 2613 2606 2607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2615 2616 2609 2610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 2617 2619 2611 2613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 2704 2705 2698 2699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 2708 2709 2702 2703 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2822 2823 2816 2817 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2973 2974 2967 2968 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3087 3088 3081 3082 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3121 3122 3115 3116 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3157 3158 3150 3151 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3160 3161 3153 3154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3163 3164 3156 3157 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3181 3182 3174 3175 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2564 3193 2558 3185 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="26">Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>) Cerebral cortex. The stellate appearance of a cortical GFP-stained cell resembling an astrocyte is presented. (<bold>b</bold>) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus which may represent a neural precursor cell. (<bold>c</bold>) Subventricular zone. These GFP-positive cells may represent self-renewing B cells of the subventricular zone. (<bold>d</bold>) Corpus callosum. Scale bar in (<bold>a</bold>) is 10&#160;&#956;m and applies to panels (<bold>a</bold>, <bold>c</bold>, <bold>d</bold>). Scale bar in (<bold>b</bold>) is 50&#160;&#956;m</p>
###xml 2564 3193 2558 3185 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="26">Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>) Cerebral cortex. The stellate appearance of a cortical GFP-stained cell resembling an astrocyte is presented. (<bold>b</bold>) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus which may represent a neural precursor cell. (<bold>c</bold>) Subventricular zone. These GFP-positive cells may represent self-renewing B cells of the subventricular zone. (<bold>d</bold>) Corpus callosum. Scale bar in (<bold>a</bold>) is 10&#160;&#956;m and applies to panels (<bold>a</bold>, <bold>c</bold>, <bold>d</bold>). Scale bar in (<bold>b</bold>) is 50&#160;&#956;m</p></caption>
###xml 3193 3193 3185 3185 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig4_HTML" id="MO4"/>
###xml 2558 3193 2552 3185 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="26">Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>) Cerebral cortex. The stellate appearance of a cortical GFP-stained cell resembling an astrocyte is presented. (<bold>b</bold>) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus which may represent a neural precursor cell. (<bold>c</bold>) Subventricular zone. These GFP-positive cells may represent self-renewing B cells of the subventricular zone. (<bold>d</bold>) Corpus callosum. Scale bar in (<bold>a</bold>) is 10&#160;&#956;m and applies to panels (<bold>a</bold>, <bold>c</bold>, <bold>d</bold>). Scale bar in (<bold>b</bold>) is 50&#160;&#956;m</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig4_HTML" id="MO4"/></fig>
###xml 3193 3199 3185 3191 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 3235 3239 3227 3231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 3240 3245 3232 3237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 3245 3247 3237 3239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 3247 3248 3239 3240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 3250 3251 3242 3243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 3252 3254 3244 3246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 3339 3340 3331 3332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 3343 3344 3335 3336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3345 3346 3337 3338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3348 3352 3340 3344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 3353 3358 3345 3350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 3358 3360 3350 3352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 3360 3361 3352 3353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 3363 3364 3355 3356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 3365 3367 3357 3359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 3434 3435 3426 3427 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3436 3437 3428 3429 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 3439 3443 3431 3435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 3444 3449 3436 3441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 3449 3451 3441 3443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 3451 3452 3443 3444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 3454 3455 3446 3447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 3456 3458 3448 3450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 3612 3613 3604 3605 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3615 3616 3607 3608 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3659 3660 3651 3652 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3662 3663 3654 3655 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 3703 3704 3695 3696 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3706 3707 3698 3699 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 3724 3725 3716 3717 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3760 3761 3752 3753 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3762 3763 3754 3755 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 3767 3768 3759 3760 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 3833 3834 3825 3826 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 3940 3941 3932 3933 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 3965 3966 3957 3958 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 3999 4000 3991 3992 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 4035 4036 4026 4027 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 4038 4039 4029 4030 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 4041 4042 4032 4033 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 4059 4060 4050 4051 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 3199 4071 3191 4061 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="27">Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with vehicle daily for 5&#160;days. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>), cerebral cortex and hippocampus (panels <bold>b</bold>, <bold>e</bold>) and thalamus and hypothalamus (panels <bold>c</bold>, <bold>f</bold>). Scale bar in (<bold>a</bold>) is 0.5&#160;mm and applies to panels (<bold>a</bold>&#8211;<bold>f</bold>). (<bold>g</bold>) High power image of GFP-positive cell in the cerebral cortex. (<bold>h</bold>) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus. (<bold>i</bold>) Subventricular zone. (<bold>j</bold>) Corpus callosum. Scale bar in (<bold>g</bold>) is 10&#160;&#956;m and applies to panels (<bold>g</bold>, <bold>i</bold>, <bold>j</bold>). Scale bar in (<bold>h</bold>) is 50&#160;&#956;m</p>
###xml 3199 4071 3191 4061 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="27">Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with vehicle daily for 5&#160;days. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>), cerebral cortex and hippocampus (panels <bold>b</bold>, <bold>e</bold>) and thalamus and hypothalamus (panels <bold>c</bold>, <bold>f</bold>). Scale bar in (<bold>a</bold>) is 0.5&#160;mm and applies to panels (<bold>a</bold>&#8211;<bold>f</bold>). (<bold>g</bold>) High power image of GFP-positive cell in the cerebral cortex. (<bold>h</bold>) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus. (<bold>i</bold>) Subventricular zone. (<bold>j</bold>) Corpus callosum. Scale bar in (<bold>g</bold>) is 10&#160;&#956;m and applies to panels (<bold>g</bold>, <bold>i</bold>, <bold>j</bold>). Scale bar in (<bold>h</bold>) is 50&#160;&#956;m</p></caption>
###xml 4071 4071 4061 4061 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig5_HTML" id="MO5"/>
###xml 3193 4071 3185 4061 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="27">Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with vehicle daily for 5&#160;days. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenic mouse injected with 9&#160;mg/40&#160;g tamoxifen daily for 5&#160;days. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>), cerebral cortex and hippocampus (panels <bold>b</bold>, <bold>e</bold>) and thalamus and hypothalamus (panels <bold>c</bold>, <bold>f</bold>). Scale bar in (<bold>a</bold>) is 0.5&#160;mm and applies to panels (<bold>a</bold>&#8211;<bold>f</bold>). (<bold>g</bold>) High power image of GFP-positive cell in the cerebral cortex. (<bold>h</bold>) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus. (<bold>i</bold>) Subventricular zone. (<bold>j</bold>) Corpus callosum. Scale bar in (<bold>g</bold>) is 10&#160;&#956;m and applies to panels (<bold>g</bold>, <bold>i</bold>, <bold>j</bold>). Scale bar in (<bold>h</bold>) is 50&#160;&#956;m</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig5_HTML" id="MO5"/></fig>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 346 350 <span type="species:ncbi:10090">Mice</span>
###xml 628 643 <span type="species:ncbi:10090">transgenic mice</span>
###xml 773 788 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
###xml 1300 1315 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1920 1925 <span type="species:ncbi:10090">mouse</span>
###xml 2023 2028 <span type="species:ncbi:10090">mouse</span>
###xml 2142 2147 <span type="species:ncbi:10090">mouse</span>
###xml 2166 2170 <span type="species:ncbi:10090">mice</span>
###xml 2271 2276 <span type="species:ncbi:10090">mouse</span>
###xml 2660 2664 <span type="species:ncbi:10090">Mice</span>
###xml 3295 3299 <span type="species:ncbi:10090">Mice</span>
###xml 3387 3392 <span type="species:ncbi:10090">mouse</span>
###xml 3477 3482 <span type="species:ncbi:10090">mouse</span>
Reporter mice were used to assess the activity of the CreERTM fusion protein following treatment with tamoxifen or vehicle. GFAP-CreERTM mice were crossed with Z/EG reporter mice in which the cDNA encoding enhanced green fluorescent protein (GFP) is expressed only after Cre-mediated excision of a LoxP-flanked stop cassette (Novak et al. 2000). Mice were injected starting at 40-50 days of age intraperitoneally with tamoxifen at a dose of 9 mg/40 g body weight or vehicle alone daily for five injections, then sacrificed at least 5 days after the last injection and tissues analyzed by immunohistochemistry for GFP. In single transgenic mice (either GFAP-CreERTM or Z/EG alone), no GFP immunoreactivity was detected in the brain (Fig. 3a-c and data not shown). In double transgenic mice injected with vehicle, occasional GFP positive cells were present, particularly in cerebellar Bergmann glia (Figs. 3d-f and 5a-c). This tamoxifen-independent Cre-mediated recombination accumulated slowly over the period of 14 months remaining predominantly localized to Bergmann glial cells (Fig. 3d, e insets) and represents the "leakiness" of this inducible Cre strain. In contrast, tamoxifen-injected mice displayed widespread GFP expression mirroring the pattern of beta-gal activity in GFAP-CreERTM single transgenic mice (Figs. 3g-i and 5d-f). Under higher magnification, the cortical staining pattern for GFP revealed cells exhibiting a stellate morphology consistent with mature astrocytes (Figs. 4a and 5g). Furthermore, GFP-expressing cells were detected in the inner layer of the dentate gyrus (Figs. 4b and 5h arrows) and in the subventricular zone (Figs. 4c and 5i) consistent with beta-gal activity (Fig. 2d, e, i, j). GFP-expressing cells were also noted in the corpus callosum (Figs. 4d and 5j).Fig. 3Cre-mediated recombination in adult brains by immunohistochemistry for GFP reporter. (a-c) Z/EG single transgenic mouse injected with 9 mg/40 g tamoxifen daily for 5 days. (d-f) GFAP-CreERTMA; Z/EG double transgenice mouse injected with vehicle daily for 5 days. Inset represents images from an uninduced 14-month-old double transgenic mouse whereas all other mice presented are ~8 weeks of age as indicated in the text. (g-i) GFAP-CreERTMA; Z/EG double transgenic mouse injected with 9 mg/40 g tamoxifen daily for 5 days. Brain regions presented are sagittal sections through the cerebellum (panels a, d, g), cerebral cortex and hippocampus (panels b, e, h) and thalamus and hypothalamus (panels c, f, i). Scale bar is 0.5 mm and applies to all panelsFig. 4Cre-mediated recombination in adult GFAP-CreERTMA; Z/EG brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig. 3. (a) Cerebral cortex. The stellate appearance of a cortical GFP-stained cell resembling an astrocyte is presented. (b) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus which may represent a neural precursor cell. (c) Subventricular zone. These GFP-positive cells may represent self-renewing B cells of the subventricular zone. (d) Corpus callosum. Scale bar in (a) is 10 mum and applies to panels (a, c, d). Scale bar in (b) is 50 mumFig. 5Cre-mediated recombination in adult GFAP-CreERTMB; Z/EG brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig. 3. (a-c) GFAP-CreERTMB; Z/EG double transgenice mouse injected with vehicle daily for 5 days. (d-f) GFAP-CreERTMB; Z/EG double transgenic mouse injected with 9 mg/40 g tamoxifen daily for 5 days. Brain regions presented are sagittal sections through the cerebellum (panels a, d), cerebral cortex and hippocampus (panels b, e) and thalamus and hypothalamus (panels c, f). Scale bar in (a) is 0.5 mm and applies to panels (a-f). (g) High power image of GFP-positive cell in the cerebral cortex. (h) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus. (i) Subventricular zone. (j) Corpus callosum. Scale bar in (g) is 10 mum and applies to panels (g, i, j). Scale bar in (h) is 50 mum
###end p 24
###begin p 25
###xml 86 87 86 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 88 89 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 91 92 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 93 95 93 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 173 174 173 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 175 176 175 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 188 190 188 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 195 197 195 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 422 423 422 423 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 424 425 424 425 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 432 437 432 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 437 439 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 444 446 444 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 600 601 600 601 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 603 604 603 604 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 606 607 606 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 650 651 650 651 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 653 654 653 654 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 656 657 656 657 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 697 698 697 698 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 700 701 700 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 703 704 703 704 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 336 341 <span type="species:ncbi:10090">mouse</span>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 465 470 <span type="species:ncbi:10090">mouse</span>
Cre-mediated recombination in adult brains by immunohistochemistry for GFP reporter. (a-c) Z/EG single transgenic mouse injected with 9 mg/40 g tamoxifen daily for 5 days. (d-f) GFAP-CreERTMA; Z/EG double transgenice mouse injected with vehicle daily for 5 days. Inset represents images from an uninduced 14-month-old double transgenic mouse whereas all other mice presented are ~8 weeks of age as indicated in the text. (g-i) GFAP-CreERTMA; Z/EG double transgenic mouse injected with 9 mg/40 g tamoxifen daily for 5 days. Brain regions presented are sagittal sections through the cerebellum (panels a, d, g), cerebral cortex and hippocampus (panels b, e, h) and thalamus and hypothalamus (panels c, f, i). Scale bar is 0.5 mm and applies to all panels
###end p 25
###begin p 26
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 53 55 53 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 144 145 144 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 258 259 258 259 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 409 410 409 410 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 523 524 523 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 557 558 557 558 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 593 594 592 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 596 597 595 596 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 599 600 598 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 617 618 616 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 96 100 <span type="species:ncbi:10090">Mice</span>
Cre-mediated recombination in adult GFAP-CreERTMA; Z/EG brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig. 3. (a) Cerebral cortex. The stellate appearance of a cortical GFP-stained cell resembling an astrocyte is presented. (b) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus which may represent a neural precursor cell. (c) Subventricular zone. These GFP-positive cells may represent self-renewing B cells of the subventricular zone. (d) Corpus callosum. Scale bar in (a) is 10 mum and applies to panels (a, c, d). Scale bar in (b) is 50 mum
###end p 26
###begin p 27
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 48 49 48 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 51 52 51 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 53 55 53 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 144 145 144 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 146 147 146 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 166 168 166 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 235 236 235 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 237 238 237 238 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 252 253 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 257 259 257 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 413 414 413 414 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 416 417 416 417 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 460 461 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 463 464 463 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 504 505 504 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 507 508 507 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 525 526 525 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 561 562 561 562 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 563 564 563 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 568 569 568 569 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 634 635 634 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 741 742 741 742 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 766 767 766 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 800 801 800 801 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 836 837 835 836 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 839 840 838 839 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 842 843 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink">j</bold>
###xml 860 861 859 860 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 96 100 <span type="species:ncbi:10090">Mice</span>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
###xml 278 283 <span type="species:ncbi:10090">mouse</span>
Cre-mediated recombination in adult GFAP-CreERTMB; Z/EG brains by immunohistochemistry for GFP. Mice were treated with tamoxifen as in Fig. 3. (a-c) GFAP-CreERTMB; Z/EG double transgenice mouse injected with vehicle daily for 5 days. (d-f) GFAP-CreERTMB; Z/EG double transgenic mouse injected with 9 mg/40 g tamoxifen daily for 5 days. Brain regions presented are sagittal sections through the cerebellum (panels a, d), cerebral cortex and hippocampus (panels b, e) and thalamus and hypothalamus (panels c, f). Scale bar in (a) is 0.5 mm and applies to panels (a-f). (g) High power image of GFP-positive cell in the cerebral cortex. (h) Dentate gyrus. The arrow indicates a GFP-stained cell located in the inner layer of the dentate gyrus. (i) Subventricular zone. (j) Corpus callosum. Scale bar in (g) is 10 mum and applies to panels (g, i, j). Scale bar in (h) is 50 mum
###end p 27
###begin p 28
###xml 234 235 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 334 335 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 433 434 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 794 798 791 795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 799 804 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 804 806 801 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1013 1014 1010 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 1155 1156 1152 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7</xref>
###xml 1158 1164 1155 1161 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 1235 1239 1232 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1240 1245 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1245 1247 1242 1244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1247 1248 1244 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1250 1251 1247 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1252 1254 1249 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 1336 1337 1333 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1340 1341 1337 1338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1342 1343 1339 1340 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1481 1482 1475 1476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1502 1503 1496 1497 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1524 1525 1518 1519 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1529 1530 1523 1524 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1531 1532 1525 1526 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1656 1657 1650 1651 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1671 1672 1665 1666 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1729 1730 1723 1724 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1763 1764 1757 1758 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1934 1935 1928 1929 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1970 1971 1963 1964 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1972 1973 1965 1966 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1990 1991 1983 1984 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 2094 2098 2086 2090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 2099 2104 2091 2096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 2104 2106 2096 2098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 2106 2107 2098 2099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1164 2129 1161 2121 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Identification of cells undergoing Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains by double immunofluorescence. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>&#8211;<bold>c</bold>) Staining with an astrocyte marker and anti-GFP. Co-immunodetection of S100&#946; (green) and GFP (red) is demonstrated in the cerebellum (<bold>a</bold>), cerebral cortex (<bold>b</bold>) and dentate gyrus (<bold>c</bold>). (<bold>d</bold>&#8211;<bold>f</bold>) Staining with a neuronal marker and anti-GFP. There is no co-immunodetection of NeuN (green) and GFP (red) in cerebellum (<bold>d</bold>) and cortex (<bold>e</bold>) while occasional granule neurons of the dentate gyrus (<bold>f</bold>) express both markers (arrow). (<bold>g</bold>) Staining with an oligodendrocyte marker and anti-GFP. Cells staining with both CC-1 (green) and GFP (red) were readily identified in the corpus callosum. Scale bar in (<bold>f</bold>) is 50&#160;&#956;m and applies to panels (<bold>a</bold>&#8211;<bold>f</bold>). Scale bar in (<bold>g</bold>) is 20&#160;&#956;m. DAPI: 4&#8242;,6-diamino-2-phenylindole (blue). Immunophenotyping results were identical in the <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> line (data not shown)</p>
###xml 1164 2129 1161 2121 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">Identification of cells undergoing Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains by double immunofluorescence. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>&#8211;<bold>c</bold>) Staining with an astrocyte marker and anti-GFP. Co-immunodetection of S100&#946; (green) and GFP (red) is demonstrated in the cerebellum (<bold>a</bold>), cerebral cortex (<bold>b</bold>) and dentate gyrus (<bold>c</bold>). (<bold>d</bold>&#8211;<bold>f</bold>) Staining with a neuronal marker and anti-GFP. There is no co-immunodetection of NeuN (green) and GFP (red) in cerebellum (<bold>d</bold>) and cortex (<bold>e</bold>) while occasional granule neurons of the dentate gyrus (<bold>f</bold>) express both markers (arrow). (<bold>g</bold>) Staining with an oligodendrocyte marker and anti-GFP. Cells staining with both CC-1 (green) and GFP (red) were readily identified in the corpus callosum. Scale bar in (<bold>f</bold>) is 50&#160;&#956;m and applies to panels (<bold>a</bold>&#8211;<bold>f</bold>). Scale bar in (<bold>g</bold>) is 20&#160;&#956;m. DAPI: 4&#8242;,6-diamino-2-phenylindole (blue). Immunophenotyping results were identical in the <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> line (data not shown)</p></caption>
###xml 2129 2129 2121 2121 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig6_HTML" id="MO6"/>
###xml 1158 2129 1155 2121 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="29">Identification of cells undergoing Cre-mediated recombination in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains by double immunofluorescence. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>&#8211;<bold>c</bold>) Staining with an astrocyte marker and anti-GFP. Co-immunodetection of S100&#946; (green) and GFP (red) is demonstrated in the cerebellum (<bold>a</bold>), cerebral cortex (<bold>b</bold>) and dentate gyrus (<bold>c</bold>). (<bold>d</bold>&#8211;<bold>f</bold>) Staining with a neuronal marker and anti-GFP. There is no co-immunodetection of NeuN (green) and GFP (red) in cerebellum (<bold>d</bold>) and cortex (<bold>e</bold>) while occasional granule neurons of the dentate gyrus (<bold>f</bold>) express both markers (arrow). (<bold>g</bold>) Staining with an oligodendrocyte marker and anti-GFP. Cells staining with both CC-1 (green) and GFP (red) were readily identified in the corpus callosum. Scale bar in (<bold>f</bold>) is 50&#160;&#956;m and applies to panels (<bold>a</bold>&#8211;<bold>f</bold>). Scale bar in (<bold>g</bold>) is 20&#160;&#956;m. DAPI: 4&#8242;,6-diamino-2-phenylindole (blue). Immunophenotyping results were identical in the <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>B</italic> line (data not shown)</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig6_HTML" id="MO6"/></fig>
###xml 2129 2135 2121 2127 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;7</label>
###xml 2184 2188 2176 2180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 2189 2194 2181 2186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 2194 2196 2186 2188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 2196 2197 2188 2189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2199 2200 2191 2192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 2201 2203 2193 2195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 2256 2257 2248 2249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 2260 2261 2252 2253 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2263 2264 2255 2256 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2483 2484 2474 2475 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2135 2522 2127 2512 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">Confocal imaging of subventricular zone in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>, <bold>b</bold>) Staining with antibodies against Gfap (green) and GFP (red) with DAPI (blue). Occasional cells co-expressing these two markers in the subventricular zone were identified in these 1&#160;&#956;m optical sections. Scale bar in (<bold>a</bold>) is 10&#160;&#956;m and applies to both panels</p>
###xml 2135 2522 2127 2512 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30">Confocal imaging of subventricular zone in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>, <bold>b</bold>) Staining with antibodies against Gfap (green) and GFP (red) with DAPI (blue). Occasional cells co-expressing these two markers in the subventricular zone were identified in these 1&#160;&#956;m optical sections. Scale bar in (<bold>a</bold>) is 10&#160;&#956;m and applies to both panels</p></caption>
###xml 2522 2522 2512 2512 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig7_HTML" id="MO7"/>
###xml 2129 2522 2121 2512 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig7"><label>Fig.&#160;7</label><caption><p textid="30">Confocal imaging of subventricular zone in adult <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> brains. Mice were treated with tamoxifen as in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>. (<bold>a</bold>, <bold>b</bold>) Staining with antibodies against Gfap (green) and GFP (red) with DAPI (blue). Occasional cells co-expressing these two markers in the subventricular zone were identified in these 1&#160;&#956;m optical sections. Scale bar in (<bold>a</bold>) is 10&#160;&#956;m and applies to both panels</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig7_HTML" id="MO7"/></fig>
###xml 814 829 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1292 1296 <span type="species:ncbi:10090">Mice</span>
###xml 2212 2216 <span type="species:ncbi:10090">Mice</span>
To confirm the cell types targeted for Cre activity, double labeling by immunofluorescence was performed. The majority of GFP-labeled cells in all regions of the brain were found to co-express S100beta, a marker for glial cells (Fig. 6a-c). In contrast, almost no GFP-labeled cells co-expressed NeuN, a marker of mature neurons (Fig. 6d-f), although the occasional double-labeled granule neuron in the dentate gyrus, was noted (Fig. 6f arrow). It is possible that such cells were Gfap-expressing neural precursors when tamoxifen was administered, then subsequently differentiated into granule neurons during the 5-10-day-period prior to analysis. Alternatively, this transgenic line may drive CreER expression in the rare mature granule neuron. However, immunophenotypical analyses of multiple GFAP-CreERTM single transgenic mice failed to identify any CreER expression in neurons (data not shown). GFP-expressing oligodendrocytes in the corpus callosum were identified by co-expression of the CC-1 antigen (Fig. 6g). Confocal microscopy was used to confirm Cre activity in occasional Gfap positive neural precursor cells of the subventricular zone (Fig. 7).Fig. 6Identification of cells undergoing Cre-mediated recombination in adult GFAP-CreERTMA; Z/EG brains by double immunofluorescence. Mice were treated with tamoxifen as in Fig. 3. (a-c) Staining with an astrocyte marker and anti-GFP. Co-immunodetection of S100beta (green) and GFP (red) is demonstrated in the cerebellum (a), cerebral cortex (b) and dentate gyrus (c). (d-f) Staining with a neuronal marker and anti-GFP. There is no co-immunodetection of NeuN (green) and GFP (red) in cerebellum (d) and cortex (e) while occasional granule neurons of the dentate gyrus (f) express both markers (arrow). (g) Staining with an oligodendrocyte marker and anti-GFP. Cells staining with both CC-1 (green) and GFP (red) were readily identified in the corpus callosum. Scale bar in (f) is 50 mum and applies to panels (a-f). Scale bar in (g) is 20 mum. DAPI: 4',6-diamino-2-phenylindole (blue). Immunophenotyping results were identical in the GFAP-CreERTMB line (data not shown)Fig. 7Confocal imaging of subventricular zone in adult GFAP-CreERTMA; Z/EG brains. Mice were treated with tamoxifen as in Fig. 3. (a, b) Staining with antibodies against Gfap (green) and GFP (red) with DAPI (blue). Occasional cells co-expressing these two markers in the subventricular zone were identified in these 1 mum optical sections. Scale bar in (a) is 10 mum and applies to both panels
###end p 28
###begin p 29
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 83 84 83 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 88 90 88 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 176 177 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 178 179 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 317 318 314 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 338 339 335 336 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 360 361 357 358 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 365 366 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 367 368 364 365 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 492 493 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 507 508 504 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 565 566 562 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 599 600 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 770 771 767 768 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 806 807 802 803 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 808 809 804 805 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 826 827 822 823 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 930 934 925 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 935 940 930 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 940 942 935 937 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 942 943 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 128 132 <span type="species:ncbi:10090">Mice</span>
Identification of cells undergoing Cre-mediated recombination in adult GFAP-CreERTMA; Z/EG brains by double immunofluorescence. Mice were treated with tamoxifen as in Fig. 3. (a-c) Staining with an astrocyte marker and anti-GFP. Co-immunodetection of S100beta (green) and GFP (red) is demonstrated in the cerebellum (a), cerebral cortex (b) and dentate gyrus (c). (d-f) Staining with a neuronal marker and anti-GFP. There is no co-immunodetection of NeuN (green) and GFP (red) in cerebellum (d) and cortex (e) while occasional granule neurons of the dentate gyrus (f) express both markers (arrow). (g) Staining with an oligodendrocyte marker and anti-GFP. Cells staining with both CC-1 (green) and GFP (red) were readily identified in the corpus callosum. Scale bar in (f) is 50 mum and applies to panels (a-f). Scale bar in (g) is 20 mum. DAPI: 4',6-diamino-2-phenylindole (blue). Immunophenotyping results were identical in the GFAP-CreERTMB line (data not shown)
###end p 29
###begin p 30
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 59 61 59 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 125 126 125 126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 128 129 128 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 348 349 347 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 77 81 <span type="species:ncbi:10090">Mice</span>
Confocal imaging of subventricular zone in adult GFAP-CreERTMA; Z/EG brains. Mice were treated with tamoxifen as in Fig. 3. (a, b) Staining with antibodies against Gfap (green) and GFP (red) with DAPI (blue). Occasional cells co-expressing these two markers in the subventricular zone were identified in these 1 mum optical sections. Scale bar in (a) is 10 mum and applies to both panels
###end p 30
###begin p 31
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 513 514 513 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">2003</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">1997</xref>
###xml 931 932 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig8" ref-type="fig">8</xref>
###xml 934 940 934 940 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;8</label>
###xml 1066 1067 1066 1067 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1068 1069 1068 1069 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1071 1075 1071 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1076 1081 1076 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1081 1083 1081 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1083 1084 1083 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1086 1087 1086 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1088 1090 1088 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 1169 1170 1169 1170 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1171 1172 1171 1172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1174 1178 1174 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1179 1184 1179 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1184 1186 1184 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1186 1187 1186 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1189 1190 1189 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1191 1193 1191 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 1272 1273 1272 1273 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1274 1275 1274 1275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 1277 1281 1277 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1282 1287 1282 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1287 1289 1287 1289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1289 1290 1289 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1292 1293 1292 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 1294 1296 1294 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 1451 1452 1451 1452 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1454 1455 1454 1455 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1457 1458 1457 1458 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 1485 1486 1485 1486 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1488 1489 1488 1489 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1491 1492 1491 1492 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 1518 1519 1518 1519 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1521 1522 1521 1522 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 1524 1525 1524 1525 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 940 1573 940 1573 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32">Dose&#8211;dependent regulation of Cre-mediated recombination by decreasing tamoxifen. Immunohistochemistry for GFP was performed. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 1&#160;mg/40&#160;g dose of tamoxifen. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 3&#160;mg/40&#160;g dose of tamoxifen. (<bold>g</bold>&#8211;<bold>i</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 9&#160;mg/40&#160;g dose of tamoxifen. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>, <bold>g</bold>), cerebral cortex (panels <bold>b</bold>, <bold>e</bold>, <bold>h</bold>) and hippocampus (panels <bold>c</bold>, <bold>f</bold>, <bold>i</bold>). Scale bar is 0.5&#160;mm and applies to all panels</p>
###xml 940 1573 940 1573 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32">Dose&#8211;dependent regulation of Cre-mediated recombination by decreasing tamoxifen. Immunohistochemistry for GFP was performed. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 1&#160;mg/40&#160;g dose of tamoxifen. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 3&#160;mg/40&#160;g dose of tamoxifen. (<bold>g</bold>&#8211;<bold>i</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 9&#160;mg/40&#160;g dose of tamoxifen. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>, <bold>g</bold>), cerebral cortex (panels <bold>b</bold>, <bold>e</bold>, <bold>h</bold>) and hippocampus (panels <bold>c</bold>, <bold>f</bold>, <bold>i</bold>). Scale bar is 0.5&#160;mm and applies to all panels</p></caption>
###xml 1573 1573 1573 1573 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="11248_2008_9185_Fig8_HTML" id="MO8"/>
###xml 934 1573 934 1573 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig8"><label>Fig.&#160;8</label><caption><p textid="32">Dose&#8211;dependent regulation of Cre-mediated recombination by decreasing tamoxifen. Immunohistochemistry for GFP was performed. (<bold>a</bold>&#8211;<bold>c</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 1&#160;mg/40&#160;g dose of tamoxifen. (<bold>d</bold>&#8211;<bold>f</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 3&#160;mg/40&#160;g dose of tamoxifen. (<bold>g</bold>&#8211;<bold>i</bold>) <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic>; <italic>Z</italic>/<italic>EG</italic> double transgenice mouse injected with a single 9&#160;mg/40&#160;g dose of tamoxifen. Brain regions presented are sagittal sections through the cerebellum (panels <bold>a</bold>, <bold>d</bold>, <bold>g</bold>), cerebral cortex (panels <bold>b</bold>, <bold>e</bold>, <bold>h</bold>) and hippocampus (panels <bold>c</bold>, <bold>f</bold>, <bold>i</bold>). Scale bar is 0.5&#160;mm and applies to all panels</p></caption><graphic position="anchor" xlink:href="11248_2008_9185_Fig8_HTML" id="MO8"/></fig>
###xml 1573 1580 1573 1580 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1653 1657 1653 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1658 1663 1658 1663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1663 1665 1663 1665 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1665 1666 1665 1666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1580 1671 1580 1671 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Quantitation of Cre-mediated recombination in different brain regions of <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> mice</p>
###xml 1580 1671 1580 1671 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Quantitation of Cre-mediated recombination in different brain regions of <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> mice</p></caption>
###xml 1671 1677 1671 1677 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Region</th>
###xml 1677 1698 1677 1698 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">% Recombination (SEM)</th>
###xml 1671 1698 1671 1698 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Region</th><th align="left">% Recombination (SEM)</th></tr>
###xml 1671 1698 1671 1698 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left">Region</th><th align="left">% Recombination (SEM)</th></tr></thead>
###xml 1698 1735 1698 1735 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Cerebellar astrocytes (Bergmann glia)</td>
###xml 1735 1745 1735 1745 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">70.8 (2.5)</td>
###xml 1698 1745 1698 1745 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Cerebellar astrocytes (Bergmann glia)</td><td align="left">70.8 (2.5)</td></tr>
###xml 1745 1764 1745 1764 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Cortical astrocytes</td>
###xml 1764 1774 1764 1774 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">52.9 (6.1)</td>
###xml 1745 1774 1745 1774 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Cortical astrocytes</td><td align="left">52.9 (6.1)</td></tr>
###xml 1774 1796 1774 1796 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hippocampal astrocytes</td>
###xml 1796 1806 1796 1806 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">44.3 (3.9)</td>
###xml 1774 1806 1774 1806 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hippocampal astrocytes</td><td align="left">44.3 (3.9)</td></tr>
###xml 1806 1838 1806 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Thalamic/hypothalamic astrocytes</td>
###xml 1838 1848 1838 1848 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">35.1 (3.4)</td>
###xml 1806 1848 1806 1848 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Thalamic/hypothalamic astrocytes</td><td align="left">35.1 (3.4)</td></tr>
###xml 1848 1880 1848 1880 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Corpus callosum oligodendrocytes</td>
###xml 1880 1884 1880 1884 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;1.0</td>
###xml 1848 1884 1848 1884 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Corpus callosum oligodendrocytes</td><td align="left">&lt;1.0</td></tr>
###xml 1884 1909 1884 1909 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Subventricular zone cells</td>
###xml 1909 1913 1909 1913 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&lt;1.0</td>
###xml 1884 1913 1884 1913 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Subventricular zone cells</td><td align="left">&lt;1.0</td></tr>
###xml 1698 1913 1698 1913 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Cerebellar astrocytes (Bergmann glia)</td><td align="left">70.8 (2.5)</td></tr><tr><td align="left">Cortical astrocytes</td><td align="left">52.9 (6.1)</td></tr><tr><td align="left">Hippocampal astrocytes</td><td align="left">44.3 (3.9)</td></tr><tr><td align="left">Thalamic/hypothalamic astrocytes</td><td align="left">35.1 (3.4)</td></tr><tr><td align="left">Corpus callosum oligodendrocytes</td><td align="left">&lt;1.0</td></tr><tr><td align="left">Subventricular zone cells</td><td align="left">&lt;1.0</td></tr></tbody>
###xml 1671 1913 1671 1913 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left">Region</th><th align="left">% Recombination (SEM)</th></tr></thead><tbody><tr><td align="left">Cerebellar astrocytes (Bergmann glia)</td><td align="left">70.8 (2.5)</td></tr><tr><td align="left">Cortical astrocytes</td><td align="left">52.9 (6.1)</td></tr><tr><td align="left">Hippocampal astrocytes</td><td align="left">44.3 (3.9)</td></tr><tr><td align="left">Thalamic/hypothalamic astrocytes</td><td align="left">35.1 (3.4)</td></tr><tr><td align="left">Corpus callosum oligodendrocytes</td><td align="left">&lt;1.0</td></tr><tr><td align="left">Subventricular zone cells</td><td align="left">&lt;1.0</td></tr></tbody></table>
###xml 1573 1913 1573 1913 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="33">Quantitation of Cre-mediated recombination in different brain regions of <italic>GFAP</italic>-<italic>CreER</italic><sup>TM</sup><italic>A</italic> mice</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Region</th><th align="left">% Recombination (SEM)</th></tr></thead><tbody><tr><td align="left">Cerebellar astrocytes (Bergmann glia)</td><td align="left">70.8 (2.5)</td></tr><tr><td align="left">Cortical astrocytes</td><td align="left">52.9 (6.1)</td></tr><tr><td align="left">Hippocampal astrocytes</td><td align="left">44.3 (3.9)</td></tr><tr><td align="left">Thalamic/hypothalamic astrocytes</td><td align="left">35.1 (3.4)</td></tr><tr><td align="left">Corpus callosum oligodendrocytes</td><td align="left">&lt;1.0</td></tr><tr><td align="left">Subventricular zone cells</td><td align="left">&lt;1.0</td></tr></tbody></table></table-wrap>
###xml 1110 1115 <span type="species:ncbi:10090">mouse</span>
###xml 1213 1218 <span type="species:ncbi:10090">mouse</span>
###xml 1316 1321 <span type="species:ncbi:10090">mouse</span>
The degree of Cre-mediated recombination was assessed by examining sections serially stained for S100 and GFP proteins in various regions of the brain (Table 1). Overall, astrocyte recombination ranged from 35% to 70% and was more efficient in the cerebellar Bergmann glia than in other parts of the brain. Interestingly, <1% of all cells in the subventricular zone showed cre-mediated recombination under the experimental conditions tested and probably represent Cre activity in the Gfap-expressing B cells (Fig 7) (Doetsch 2003). This population has been reported to comprise 20-25% of cells in the subventricular zone (Doetsch et al. 1997). Increasing the dose of tamoxifen administered did not result in further elevations in the number of GFP positive cells (data not shown), however, recombination could be restricted to fewer astrocytes by titrating the drug dose from 9 to 1 mg/40 g body weight in a single injection (Fig. 8).Fig. 8Dose-dependent regulation of Cre-mediated recombination by decreasing tamoxifen. Immunohistochemistry for GFP was performed. (a-c) GFAP-CreERTMA; Z/EG double transgenice mouse injected with a single 1 mg/40 g dose of tamoxifen. (d-f) GFAP-CreERTMA; Z/EG double transgenice mouse injected with a single 3 mg/40 g dose of tamoxifen. (g-i) GFAP-CreERTMA; Z/EG double transgenice mouse injected with a single 9 mg/40 g dose of tamoxifen. Brain regions presented are sagittal sections through the cerebellum (panels a, d, g), cerebral cortex (panels b, e, h) and hippocampus (panels c, f, i). Scale bar is 0.5 mm and applies to all panelsTable 1Quantitation of Cre-mediated recombination in different brain regions of GFAP-CreERTMA miceRegion% Recombination (SEM)Cerebellar astrocytes (Bergmann glia)70.8 (2.5)Cortical astrocytes52.9 (6.1)Hippocampal astrocytes44.3 (3.9)Thalamic/hypothalamic astrocytes35.1 (3.4)Corpus callosum oligodendrocytes<1.0Subventricular zone cells<1.0
###end p 31
###begin p 32
###xml 126 127 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 128 129 128 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 141 143 141 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 148 150 148 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 229 230 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 231 232 231 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 239 244 239 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 244 246 244 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 251 253 251 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 332 333 332 333 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 334 335 334 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 347 349 347 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Z</italic>
###xml 354 356 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EG</italic>
###xml 511 512 511 512 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 514 515 514 515 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 517 518 517 518 <bold xmlns:xlink="http://www.w3.org/1999/xlink">g</bold>
###xml 545 546 545 546 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 548 549 548 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 551 552 551 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">h</bold>
###xml 578 579 578 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 581 582 581 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f</bold>
###xml 584 585 584 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink">i</bold>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
###xml 273 278 <span type="species:ncbi:10090">mouse</span>
###xml 376 381 <span type="species:ncbi:10090">mouse</span>
Dose-dependent regulation of Cre-mediated recombination by decreasing tamoxifen. Immunohistochemistry for GFP was performed. (a-c) GFAP-CreERTMA; Z/EG double transgenice mouse injected with a single 1 mg/40 g dose of tamoxifen. (d-f) GFAP-CreERTMA; Z/EG double transgenice mouse injected with a single 3 mg/40 g dose of tamoxifen. (g-i) GFAP-CreERTMA; Z/EG double transgenice mouse injected with a single 9 mg/40 g dose of tamoxifen. Brain regions presented are sagittal sections through the cerebellum (panels a, d, g), cerebral cortex (panels b, e, h) and hippocampus (panels c, f, i). Scale bar is 0.5 mm and applies to all panels
###end p 32
###begin p 33
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 83 85 83 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Quantitation of Cre-mediated recombination in different brain regions of GFAP-CreERTMA mice
###end p 33
###begin title 34
Discussion
###end title 34
###begin p 35
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 9 14 9 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 14 16 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
The GFAP-CreERTM mouse lines described in this report represent useful tools for investigators interested in studying the effects of gene manipulation in mature astrocytes. Virtually no Cre activity is present in neurons, specifically in the cortex, allowing for the study of cell autonomous phenomena in this cell population. This may be particularly relevant to the fields of brain injury and repair as well as to gliomagenesis. Furthermore, the presence of detectable Cre activity in a subset of adult neural precursor cells in the dentate gyrus and the subventricular zone may also facilitate the study of regenerative and oncogenic potentials of this increasingly scrutinized cell population.
###end p 35
###begin p 36
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T2</sup>
###xml 110 114 110 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">1999</xref>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2007</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2006</xref>
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">2006</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2007</xref>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">2007</xref>
###xml 943 947 943 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">2006</xref>
###xml 1163 1167 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">2006</xref>
###xml 1183 1187 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">2007</xref>
###xml 1517 1521 1517 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1522 1527 1522 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1527 1529 1527 1529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1529 1530 1529 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1551 1552 1551 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1560 1561 1560 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 1569 1570 1569 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1900 1904 1900 1904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GFAP</italic>
###xml 1905 1910 1905 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CreER</italic>
###xml 1910 1912 1910 1912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 1912 1913 1912 1913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 1064 1069 <span type="species:ncbi:10090">mouse</span>
###xml 1990 1995 <span type="species:ncbi:10090">mouse</span>
Recently, similar transgenic mouse lines have been reported in which the CreERT2 fusion protein (Indra et al. 1999) was expressed under the control of the identical GFAP promoter (Casper et al. 2007; Ganat et al. 2006; Hirrlinger et al. 2006). One report described CreER activity in young (five-day-old) mice and found that neural precursor cells were significantly targeted at this age (Ganat et al. 2006). Interestingly, these cells went on to differentiate into mature neurons, oligodendrocytes and astrocytes in vivo taking residence in all regions of the brain. We have yet to examine CreER activity in our juvenile mice. Two other groups have documented CreER activity in adult astrocytes (Casper et al. 2007; Hirrlinger et al. 2006). One line appears to have broad activity in astrocytes, although quantitation was not reported (Casper et al. 2007), while the other is more restricted to certain regions of the brain (Hirrlinger et al. 2006). Neither group commented on CreER activity in adult neural precursor cells. Other astrocyte-specific inducible Cre mouse strains have also been described with activity in adult neural progenitor cells (Mori et al. 2006; Slezak et al. 2007). We describe CreER activity in a broad range of adult astrocytes as well as in a restricted population of adult neural progenitor cells. While the pattern of expression is largely similar between our two lines, the degree of CreER expression and consequently of recombination in astrocytes appears to be slightly greater in the GFAP-CreERTMA line (compare Figs. 2a-f and 3h, i to 5e, f). In addition, by using a less sensitive variant of the CreER fusion protein, we demonstrated an easily achievable dose-response effect to tamoxifen that may be advantageous for certain studies, such as cell-fate mapping and tumorigenesis. We have successfully generated spontaneous models for diffuse astrocytomas using our GFAP-CreERTMA line (L.M.L.C. and S.J.B., unpublished data). Together, these various CreER mouse lines provide novel and powerful tools for investigators to probe normal and pathological astrocyte functions.
###end p 36
###begin title 37
Acknowledgements
###end title 37
###begin p 38
###xml 112 127 <span type="species:ncbi:10090">transgenic mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 574 582 <span type="species:ncbi:9606">Children</span>
We thank D. Gutmann and A. McMahon for the gift of reagents and L. Li for technical expertise in generating the transgenic mice. J. Mitchell's role in genotyping mice was indispensable. We acknowledge J.M. Lahti and V.A. Valentine from the Cancer Center Core Cytogenetics Laboratory for FISH analyses. L.M.L.C. is a recipient of the Jean-Francois St.-Denis Fellowship in Cancer Research from the Canadian Institutes of Health Research. S.J.B is supported by grants from the National Institutes of Health and the American Lebanese and Syrian Associated Charities of St. Jude Children's Research Hospital.
###end p 38
###begin p 39
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 39
###begin title 40
References
###end title 40
###begin article-title 41
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation
###end article-title 41
###begin article-title 42
###xml 5 20 <span type="species:ncbi:10090">transgenic mice</span>
GFAP transgenic mice
###end article-title 42
###begin article-title 43
###xml 55 70 <span type="species:ncbi:10090">transgenic mice</span>
GFAP promoter directs astrocyte-specific expression in transgenic mice
###end article-title 43
###begin article-title 44
GFAP-positive progenitor cells produce neurons and oligodendrocytes throughout the CNS
###end article-title 44
###begin article-title 45
Characterization of astrocyte-specific conditional knockouts
###end article-title 45
###begin article-title 46
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
Inducible Cre recombinase activity in mouse cerebellar granule cell precursors and inner ear hair cells
###end article-title 46
###begin article-title 47
The glial identity of neural stem cells
###end article-title 47
###begin article-title 48
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain
###end article-title 48
###begin article-title 49
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Ligand-activated site-specific recombination in mice
###end article-title 49
###begin article-title 50
Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo
###end article-title 50
###begin article-title 51
Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo
###end article-title 51
###begin article-title 52
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Conditional gene targeting in the mouse nervous system: insights into brain function and diseases
###end article-title 52
###begin article-title 53
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse
###end article-title 53
###begin article-title 54
Glial cells more than support cells?
###end article-title 54
###begin article-title 55
Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2
###end article-title 55
###begin article-title 56
Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases
###end article-title 56
###begin article-title 57
Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes
###end article-title 57
###begin article-title 58
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease
###end article-title 58
###begin article-title 59
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum
###end article-title 59
###begin article-title 60
Selective ablation of alphav integrins in the central nervous system leads to cerebral hemorrhage, seizures, axonal degeneration and premature death
###end article-title 60
###begin article-title 61
Inducible gene deletion in astroglia and radial glia-a valuable tool for functional and lineage analysis
###end article-title 61
###begin article-title 62
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision
###end article-title 62
###begin article-title 63
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
Transgenic mice for conditional gene manipulation in astroglial cells
###end article-title 63
###begin article-title 64
###xml 10 25 <span type="species:ncbi:10090">transgenic mice</span>
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
###end article-title 64

